...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80
【24h】

Cellular Mechanisms Controlling Surfacing of AICL Glycoproteins, Cognate Ligands of the Activating NK Receptor NKp80

机译:控制AiCl糖蛋白的表面的细胞机制,活化NK受体NKP80的同源配体

获取原文
获取原文并翻译 | 示例

摘要

AICL glycoproteins are cognate activation-induced ligands of the C-type lectin-like receptor NKp80, which is expressed on virtually all mature human NK cells, and NKp80-AICL interaction stimulates NK cell effector functions such as cytotoxicity and cytokine secretion. Notably, AICL and NKp80 are encoded by adjacent genes in the NK gene complex and are coexpressed by human NK cells. Whereas AICL is intracellularly retained in resting NK cells, exposure of NK cells to proinflammatory cytokines results in AICL surfacing and susceptibility to NKp80-mediated NK fratricide. In this study, we characterize molecular determinants of AICL glycoproteins that cause intracellular retention, thereby controlling AICL surface expression. Cys(87) residing within the C-type lectin-like domain not only ensures stable homodimerization of AICL glycoproteins by disulfide bonding, but Cys(87) is also required for efficient cell surface expression of AICL homodimers and essential for AICL-NKp80 interaction. In contrast, cytoplasmic lysines act as negative regulators targeting AICL for proteasomal degradation. One atypical and three conventional N-linked glycosylation sites in the AICL C-type lectin-like domain critically impact maturation and surfacing of AICL, which is strictly dependent on glycosylation of at least one conventional glycosylation site. However, although the extent of conventional N-linked glycosylation positively correlates with AICL surface expression, the atypical glycosylation site impairs AICL surfacing. Stringent control of AICL surface expression by glycosylation is reflected by the pronounced interaction of AICL with calnexin and the impaired AICL expression in calnexin-deficient cells. Collectively, our data demonstrate that AICL expression and surfacing are tightly controlled by several independent cellular posttranslational mechanisms.
机译:AiCl糖蛋白是C型凝集素状的受体NKP80的同源活化诱导的配体,其在几乎所有成熟的人NK细胞上表达,NKP80-AICL相互作用刺激NK细胞效应器函数,例如细胞毒性和细胞因子分泌。值得注意的是,AIC1和NKP80由NK基因复合物中的相邻基因编码,并由人NK细胞共置。然而,AIC1在静息NK细胞中细胞内保留,NK细胞暴露于促炎细胞因子导致AICL表面的浮出水性和对NKP80介导的NK Fratricide的易感性。在该研究中,我们表征了导致细胞内保留的AICL糖蛋白的分子决定因素,从而控制AICL表面表达。 Cys(87)驻留在C型凝集素样域内的型号不仅可以通过二硫键确保AICL糖蛋白的稳定同态化,但是Cys(87)也需要AIC1同型二聚体的有效细胞表面表达,并且对于AICL-NKP80相互作用是必需的。相反,细胞质赖氨酸用作靶向AIC1的负调节剂,用于蛋白酶体降解。在AIC1 C型凝集素状域中的一种非典型和三种常规的N-连接糖基化位点,其AIC1的效果和表面的效果和表面,其严格依赖于至少一种常规糖基化位点的糖基化。然而,尽管常规的N-连接糖基化的程度与AIC1表面表达具有正相关,但非典型糖基化位点损害AICL表面。通过糖基化的AIC1表面表达的严格控制被AICL与Calnexin的发音相互作用和Calnexin缺陷细胞中的AIC1表达受损。集体,我们的数据表明,AICL表达和浮面通过几个独立的细胞后期改变机制紧密控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号